Quality CDMO
Generated 5/10/2026
Executive Summary
Quality CDMO is a contract development and manufacturing organization based in Fort Worth, Texas, specializing in liquid and semi-solid formulations for OTC drugs, prescription products, dietary supplements, and professional skincare. Founded in 2018, the company operates a cGMP-compliant, FDA-registered facility emphasizing quality assurance and regulatory compliance. Its customized solutions cater to a diverse client base, from startups to established brands, leveraging expertise in creams, lotions, ointments, and suppositories. The company's focus on niche formulations positions it well in the growing CDMO market, particularly as outsourcing trends accelerate among pharma and consumer health companies. With a flexible business model and a strong emphasis on quality, Quality CDMO is poised to capitalize on increasing demand for specialized manufacturing. The private company has yet to disclose financials but operates in a sector projected to grow at a CAGR of 8-10% over the next five years. Key growth drivers include the expansion of OTC and nutraceutical markets, as well as the trend toward personalized skincare. While competition is intense, Quality CDMO's targeted capabilities and regulatory adherence provide a foundation for capturing market share. Future success will depend on scaling capacity and securing long-term client partnerships.
Upcoming Catalysts (preview)
- Q3 2026Major Client Contract Announcement40% success
- Q4 2026Facility Expansion or New Manufacturing Line30% success
- TBDFDA Approval for New Product Category (e.g., sterile products)20% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)